A Randomized Clinical Trial To Study Losartan On Endothelial Dysfunction and Insulin Resistance In Obese Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Mark A Creager, MD
Brigham and Women's Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cavs Clinical Research Center
Little Rock, Arkansas, United States
- Va San Diego Health Care System
San Diego, California, United States
- University of Miami Diabetes Research Institute
Miami, Florida, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- Brigham and Women'S Hospital Cardiovascular Division
Boston, Massachusetts, United States
- St. Lukes Roosevelt Hospital
New York, New York, United States
- University of Pennsylvania School of Medicine
Philadelphia, Pennsylvania, United States
- University of Texas Sw Medical Center at Dallas
Dallas, Texas, United States
- Hypertension Clinical Pharmacology Baylor Clinic
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Dec 2008
- Completion
- 31 Dec 2008
- Last update posted
- 6 Sept 2018
- Registered enrollment
- 53
- Registry id
- NCT00675987
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.